Filter
5609
Filtered Results: 5609
Text search:
drug
development
Featured
Recommendations
489
New Publications
1474
Language
Document type
No document type
3337
Studies & Reports
906
Guidelines
699
Manuals
252
Strategic & Response Plan
183
Fact sheets
82
Training Material
81
Situation Updates
22
Infographics
14
Resource Platforms
12
Brochures
10
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
315
Global
209
Kenya
177
South Africa
134
Ethiopia
131
Uganda
129
Nigeria
119
Western and Central Europe
110
Tanzania
106
Nepal
101
Sierra Leone
92
Zambia
90
Liberia
89
Malawi
85
Africa
83
Myanmar / Burma
81
Latin America and the Carribbean
77
Ghana
75
Bangladesh
72
Rwanda
66
Namibia
61
Ukraine
57
Eastern Europe
57
Philippines
52
Asia
45
Zimbabwe
44
Cambodia
40
South–East Asia Region
40
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Colombia
19
Germany
19
East and Southern Africa
18
Brazil
17
South Sudan
17
Cameroon
16
Haiti
15
West and Central Africa
15
USA
14
Middle East and North Africa
14
Tajikistan
13
Thailand
12
Albania
12
Venezuela
12
China
11
Vietnam
11
Pakistan
11
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Georgia
9
Argentina
8
Sudan
8
Laos
7
Armenia
7
Paraguay
7
Moldova
7
Sri Lanka
7
Mexico
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
El Salvador
5
Benin
5
Peru
5
Lebanon
5
Central African Republic
5
Iraq
5
Timor Leste/ East Timor
4
Iran
4
Jordan
4
Jamaica
4
United Kingdom
4
Mali
4
Bhutan
4
Somalia
4
Madagascar
4
Turkey
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Honduras
3
Angola
3
Libya
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Nicaragua
2
Poland
2
Chad
2
Ecuador
2
Guatemala
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Egypt
1
Romania
1
Greece
1
Authors & Publishers
Publication Years
Category
Countries
2187
Clinical Guidelines
481
Public Health
271
Women & Child Health
216
Key Resources
159
Capacity Building
87
Pharmacy & Technologies
67
Annual Report MEDBOX
1
Toolboxes
HIV
643
Mental Health
552
TB
534
AMR
288
NTDs
247
COVID-19
209
Pharmacy
161
NCDs
120
Caregiver
110
Malaria
102
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Rapid Response
65
Disability
65
Global Health Education
63
Conflict
58
Health Financing Toolbox
55
2.0 Rapid Response
28
Polio
22
Natural Hazards
20
Zika
17
Specific Hazards
16
Cholera
16
Social Ethics
15
Based on the Vulnerability Index developed in this review, an estimated 22.7 million persons in Myanmar, or 44% of the population, were found to have some form of vulnerability related to human development and/or exposure to active conflict/violence. These people experience varying combinations of p...
Purpose of these Guidelines
These guidelines are designed to help members of the public to provide first aid to someone who is at risk of suicide. The role of the first aider is to assist the person until appropriate professional help is received or the crisis resolves.
Development of these Guidel...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
The Rwandan Ministry of Health recognizes the threat that Non-Communicable Diseases (NCDs) pose to health and development in Rwanda and in 2009 articulates strategies to respond to them in the Health Sector Strategic Plan 2012 - 2018 (HSSP3). Among other things, the plan calls for a national prevale...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
Tuberculosis (TB) remains a significant global health challenge, with an estimated annual death rate of approximately one per 100,000 people in countries with low TB prevalence. Rapid reductions in TB cases and deaths worldwide depend on research breakthroughs, including the development of new vac...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl...
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
